CN1408404A - Cancer curing medicine - Google Patents
Cancer curing medicine Download PDFInfo
- Publication number
- CN1408404A CN1408404A CN 02125552 CN02125552A CN1408404A CN 1408404 A CN1408404 A CN 1408404A CN 02125552 CN02125552 CN 02125552 CN 02125552 A CN02125552 A CN 02125552A CN 1408404 A CN1408404 A CN 1408404A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cancer
- effect
- cell
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 201000011510 cancer Diseases 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 4
- 235000008434 ginseng Nutrition 0.000 claims abstract description 4
- 210000002826 placenta Anatomy 0.000 claims abstract description 4
- 210000003734 kidney Anatomy 0.000 claims description 19
- 210000000952 spleen Anatomy 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 12
- 210000002784 stomach Anatomy 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 7
- 230000001737 promoting effect Effects 0.000 claims description 7
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 206010017758 gastric cancer Diseases 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 201000011549 stomach cancer Diseases 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 3
- 240000000588 Hericium erinaceus Species 0.000 claims description 3
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241001646826 Isodon rubescens Species 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 3
- 241001250596 Pleione Species 0.000 claims description 3
- 241000222640 Polyporus Species 0.000 claims description 3
- 201000008275 breast carcinoma Diseases 0.000 claims description 3
- 244000309464 bull Species 0.000 claims description 3
- 108010052008 colla corii asini Proteins 0.000 claims description 3
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 3
- 201000004637 gastric cardia carcinoma Diseases 0.000 claims description 3
- 229950010604 pancreas powder Drugs 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 2
- 241000545744 Hirudinea Species 0.000 claims description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 201000002313 intestinal cancer Diseases 0.000 claims description 2
- 238000011068 loading method Methods 0.000 claims description 2
- 238000000643 oven drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 235000001667 Vitex agnus castus Nutrition 0.000 claims 1
- 244000063464 Vitex agnus-castus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 37
- 210000004881 tumor cell Anatomy 0.000 abstract description 14
- 230000001939 inductive effect Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- 206010027476 Metastases Diseases 0.000 abstract description 6
- 230000000903 blocking effect Effects 0.000 abstract description 4
- 230000011278 mitosis Effects 0.000 abstract description 4
- 241000208340 Araliaceae Species 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000009401 metastasis Effects 0.000 abstract description 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 230000032823 cell division Effects 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 31
- 235000009508 confectionery Nutrition 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 8
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 7
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 229930014456 matrine Natural products 0.000 description 7
- 102000014150 Interferons Human genes 0.000 description 6
- 108010050904 Interferons Proteins 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 6
- 229940079322 interferon Drugs 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000024245 cell differentiation Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000357 carcinogen Toxicity 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 230000018199 S phase Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000003725 endotheliocyte Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 240000009087 Crescentia cujete Species 0.000 description 1
- 235000005983 Crescentia cujete Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000009797 Lagenaria vulgaris Nutrition 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a cancer curing medicine preparation. It is prepared with 23 kinds of Chinese medicinal materials, including ginseng, astragalus root, human placenta, ass-hide glue, etc. which are prepared into extract and further prepared into capsule and tablet. It has the pharmaceological functions of strengthening body's immunity, blocking cancer metastasis, inducing cell division and death, inhibiting the mitosis of tumor cell, destroying the surface protein membrane o tumor cell, etc. Clinical application shows its obvious curative effect and no toxic side effect.
Description
The prescription source:
Tradition traditional Chinese medical science secret recipe combines with my clinical practice for many years, based on motherland's Traditional Chinese medical theory, adopts modern new herbal pharmacology and scientific achievement, carries out a series of scientific composition.The prescription of trying hard to reaches perfect, truly has curative effect through clinical trial.Prescription: Radix Ginseng 15g Radix Astragali Preparata 20g Placenta Hominis 15g Colla Corii Asini 15g Cornu Cervi Pantotrichum 15g Radix Panacis Quinquefolii 15g (process by urine of baby boys, extractum) (extractum) (extractum) (extractum) (extractum) (extractum) Fructus Mori 15g Semen Cuscutae 15g Radix Et Caulis Acanthopanacis Senticosi 20g pancreas powder 30g Hericium erinaceus (Bull. Ex Fr.) Pers. 15g Coriolous Dersicolor (Fr.) Quel 15g (process by horse urine, extractum) (urine of baby boys is processed, extractum) (extractum) (extractum) (extractum) (extractum) Polyporus 20g Radix Sophorae Flavescentis 15g Herba Equiseti Arvinsis 20g Rabdosia rubescens 15g Herba Hedyotidis Diffusae 30g Herba Sarcandrae 20g (process by urine of baby boys, extractum) (urine of baby boys is processed, extractum) (extractum) (extractum) (extractum) (extractum) Herb Gynostemmae Pentaphylli 20g Lentinus Edodes 15g Herba Chelidonii 15g Pseudobulbus Cremastrae Seu Pleiones 20g unprocessed leech 30g (extractum) (extractum) (extractum) (extractum) separates the side: Radix Ginseng: sweet, little hardship, tepor.Strongly invigorating primordial QI, tonifying the lung spleen invigorating, promoting the production of body fluid and inducing sedation of the mind.Pharmacology:
One, modern study proves, has the effect of human body immunity improving function;
Two, studies show that to have the effect of inducing cell differentiation;
Three, has the effect that strengthens hemopoietic function of bone marrow; Radix Astragali Preparata: sweet, tepor.Invigorating the spleen and replenishing QI, consolidating superficial resistance and inducing diuresis.Pharmacology:
One, modern study proves, has the enhancing human body immunity function and improves the reticuloendothelial system function
Effect; Placenta Hominis: sweet, salty, warm.Go into lung, liver, kidney channel.Benefiting qi and nourishing blood, the kidney warming benefit is smart.Pharmacology:
One, modern study proves, this product contains the interferon composition, has antitumor action.
Two, has the effect that recovers hemopoietic function of bone marrow.Colla Corii Asini: sweet, flat.Go into lung, liver, kidney channel.Nourshing Yin and drynsessmoistening prescription, tonifying blood and arresting bleeding.Pharmacology:
One, studies show that, promote erythrocyte and hemoglobin cell regeneration.Cornu Cervi Pantotrichum: sweet, salty, warm.Invigorating kidney-YANG, replenishing vital essence and blood.
Pharmacology: one, studies have shown that, promote erythrocyte, the plain regeneration of hematochrome and reticulocyte.Radix Panacis Quinquefolii: sweet, little hardship, cold.Go into the heart, lung, kidney channel.YIN nourishing and the production of body fluid promoting is good for the stomach, clear asthenic fire.
Pharmacology: one, clinical practice proves, pays effect to the poison that chemicotherapy causes, can play attenuation synergistic.And
The effect of leukocyte increasing is arranged.Fructus Mori: sweet, sour, cool.Go into conscience, kidney channel.Nourishing the liver and kidney, nourishing blood to expel wind.
Pharmacology: one, modern study proves, this product contains the plain composition of calabash Radix Raphani, and it can stop carcinogen to cause
Cell mutation, intracellular lysosome is broken, emit hydrolytic enzyme, make cancerous cell molten
Separate death.Semen Cuscutae: hot, sweet, flat.Go into liver, kidney channel.Invigorating the liver and kidney, beneficial marrow.
Pharmacology: one, modern study proves, this product contains vitamin A, can stop carcinogen with DNA closely
In conjunction with, strengthen anti-infection ability, the natural adaptation mechanism of while enhancing body, thus repair
Multiple impaired DNA stops tumor propagation.Even make tumor regression or reverse for normal thin
Born of the same parents.Radix Et Caulis Acanthopanacis Senticosi: suffering, hardship, temperature.Go into liver, kidney channel.Replenishing QI to invigorate the spleen, the kidney tonifying benefit is smart.
Pharmacology: studies have shown that one, this product contains Radix Et Caulis Acanthopanacis Senticosi polysaccharide, have inducement interferon (INF) effect.
Two, have the tumor of delay and take place, stop the effect of neoplasm metastasis.
Studies have shown that three, this product has the effect that alleviates toxicity of anticancer agents.Pancreas powder: sweet, flat.The lung benefiting spleen invigorating is moisturized.Be used for the treatment of various tumors.
Pharmacology: one, the famous treatment of cancer expert of U.S. doctor Li Zhidexun is through 4,000 above patient's clinical practice cards
Bright, contain the plain composition of pancreas in the animal pancreas, it can melt the albumen that forms the cancerous protuberance epithelium, makes cancer
Cell is easily by the immunocyte Hericium erinaceus (Bull. Ex Fr.) Pers. that eats: sweet, flat.Go into stomach, spleen, kidney channel.Reinforcing spleen and kidney.Anticancer.Be used for the treatment of multiple cancer.
Pharmacology: one, modern study proves, in vitro tests can suppress the DNA of EC cancer cell and closing of RNA
Become, stop mixing of thymus pyrimidine deoxyribonucleotide and uridylate, to reach anti-
The purpose of cancer.
Two, this product contains polypeptide, polysaccharide, can improve lymhocyte transformation rate, and can produce interference
Plain (INF) Coriolous Dersicolor (Fr.) Quel: sweet, light, be slightly cold.Go into spleen, liver, stomach warp.Invigorating spleen to remove dampness, anticancer.
Pharmacology: one, studies show that, have and recover and therapeutical effect to the caused immunologic hypofunction of chemicotherapy.Polyporus: sweet, light, flat.Go into spleen, kidney, urinary bladder channel.The diuresis eliminating dampness by diuresis.Be used for the treatment of kinds of tumors.
Pharmacology: one, modern study shows, this product contains the polyporusum bellatus composition, and many polysaccharide that experiment showed, are passable
Impel the inducing leukemia cell differentiation, make it cancerous tumor cell and transform to normal cell.Radix Sophorae Flavescentis: bitter, cold, slightly poisonous.Go into the heart, liver, stomach, kidney, intestinal warp.Heat clearing and damp drying.Be used for the treatment of kinds of tumors.
Pharmacology: studies have shown that one, this product contains matrine, it can have inhibitory action to multiple transplanted tumor, can
Improve host's organism metabolism.
Studies have shown that two, matrine can obviously suppress the adhesion of tumor cell and endotheliocyte, stop
Neoplasm metastasis.
Prove after deliberation that three, matrine has differentiation to the K562 cell, matrine can reduce
The grade malignancy of SmmC---7211 cells and make it trend towards normal cell.And it is right
SGC---7901 cells have apoptosis-induced effect.Herba Equiseti Arvinsis: bitter, cool.Clearing away heat and cooling blood, the cough-relieving diuresis, anticancer.
Pharmacology: one, modern study proves, this product silicon-containing compound can promote increasing of connective tissue and collagen tissue
Give birth to, and form barrier.This barrier can stop the fast breeding and the diffusion of cancerous cell.Rabdosia rubescens: hardship, sweet, cold.Go into lung, the stomach warp.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, anticancer.Be used for the treatment of multiple cancer.
Pharmacology: studies have shown that one, this product contains rubescensine A, DNA capable of blocking is synthetic on the one hand for it, a side
Face can suppress the tumor cell mitosis, makes it to stop at the S phase.Herba Hedyotidis Diffusae: bitter, sweet, cold.Go into spleen, stomach, the heart, liver, intestinal warp.Heat-clearing and toxic substances removing, the eliminating carbuncle of invigorating blood circulation, anticancer.With
In the treatment kinds of tumors.
Pharmacology: one, in vivo test proves, S-180 is had the obvious suppression effect.Can make the cancerous cell karyokinesis, the spy
Not to have silk to divide silk to split significantly to be suppressed, make tumor body degeneration necrosis.
Two, people such as Huang Jing of institute of oncology of China Concord Medical Science University of the Chinese Academy of Medical Sciences is through grinding
Study carefully and find that this product contains the ursolic acid composition, can induce the apoptosis of HL-60 cell.Herba Sarcandrae: suffering, bitter, flat.Slightly poisonous.Go into liver, the intestinal warp.Heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis.Be used for the treatment of multiple swollen
Tumor.
Pharmacology: one, evidence, this product can get high oxidation hydrogen enzyme activity, to the consumption of tumor cell and tumor mice
The oxygen ability has direct repression.Herb Gynostemmae Pentaphylli: bitter, cold.Go into the heart, liver, spleen, lung meridian.Eliminating inflammation and expelling toxin, anticancer.Be used for the treatment of multiple cancer.
Pharmacology: one, modern study proves, this product main component is a gypenoside.Multiple cancer all there is inhibition
Effect.This product can prevent the normal cell canceration, and impels the merit of cell performance self-regeneration
Can, induce cancerous tumor cell to recover normal.Lentinus Edodes: sweet, flat.Go into the heart, stomach, spleen, kidney channel.
Pharmacology: one, modern study proves, the antitumaous effect of this product is by the lentinan enhancing body that becomes to assign to
Immunologic function and inducement interferon (INF) effect.Herba Chelidonii: hardship, cold.Slightly poisonous.Go into lung, stomach warp.Reducing swelling and alleviating pain.The diuretic cough-relieving.Be used for the treatment of digestive tract tumor.
Pharmacology: studies have shown that one, this product contains Herba Chelidonii, multiple alkaloid such as former opium is salty has the inhibition tumor
The cell mitogen effect.Pseudobulbus Cremastrae Seu Pleiones: sweet, little suffering, cold.Slightly poisonous.Go into liver, spleen, stomach warp.Removing toxic substances and promoting subsidence of swelling, blood stasis-eliminating and stagnation-dissipating.Be used for the treatment of many
Plant cancer.
Pharmacology: prove after deliberation that one, this product contains colchicine and derivant Colchiceinamidum thereof, have the tumor of inhibition thin
The mitotic effect of born of the same parents makes it to stop at mid-term, and resistance DNA is synthetic, to kinds of tumors
Therapeutical effect is arranged.
Two, can suppress cancerous cell in the blood, stop hematogenous metastasis.
Three, test shows that colchicine can suppress the scar tissue hypertrophy after deliberation.Hirudo: salty, bitter, flat.The removing blood stasis dissipating blood stasis, the abdominal mass that disappears of stimulating the menstrual flow.
Pharmacology: one, show after deliberation, help cancer therapy drug and immunologically competent cell and enter interior of tumor cell
Wave anti-tumor effect.
Indication and functional adaptation card: the esophageal carcinoma, gastric cancer, carcinoma of gastric cardia, breast carcinoma, hepatocarcinoma, pulmonary carcinoma, intestinal cancer and multiple cancer.
Function: benefiting QI and nourishing blood, YIN nourishing and the production of body fluid promoting, warming the kidney to activate YANG, enriching yin and nourishing kidney, invigorating the spleen and regulating the stomach.
The effect of pharmacological action one, enhancing human body immunity function: studies have shown that this medical instrument has enhancing and promotes specific immunity
And non-specific immunity has effect.Two, inducing tumor cell differentiation and effect of apoptosis: modern study shows that this medical instrument is induced urgency
Property non-lymphocytic leukemia cell, urgency
Grain list and monokaryon grain leukaemia, HL
-60 cells, the effect of K562 cell differentiation.
Making it cancerous cell transforms to normal cell.Warp
Test shows, and is thin to HL-60 simultaneously
Born of the same parents, SGC-9701 cell have apoptosis and do
With.Three, suppress tumor cell mitosis, the synthetic effect of blocking dna: studies show that this medicine
Can suppress tumor cell
Mitosis makes it
Stop at S phase and M
Phase, blocking dna closes
Become.And to multiple cancer
Tumor has inhibitory action.Four, destroy the effect of tumor surface cell membrane: clinical to thousands of names through the famous treatment of cancer expert of the U.S.
The host observes proof, has to melt away to form the carcinoma skin
The albumen on film surface makes it to be gulped down easily by immunocyte
The effect of food is with the purpose that reaches anticancer, changes cancer.Five, the effect of inducing tumor cell reverse: studies show that this medicine can prevent cell carcinogenesis, has cell
The function of self-regeneration disappears carcinoma or reverses to be voluntarily
Normal cell.Six, impel cancerous cell to produce the effect of self-dissolving: to studies have shown that this medicine can stop carcinogen to cause
Cell mutation breaks intracellular lysosome, puts
Go out hydrolytic enzyme, make cancerous cell dissolve apoptosis voluntarily.Seven, postpone tumor and take place, stop the effect of neoplasm metastasis: studies have shown that this medicine can promote knot to form
The hypertrophy of tissue and collagen tissue, and
Form barrier, thereby stop tumor to expand
Loose and transfer.Proof can be obvious simultaneously
Inhibition tumor cell and endotheliocyte
Adhere to and stop neoplasm metastasis.Eight, suppress the outgrowth effect of tumor scar tissue: prove that after deliberation this medicine has the scar tissue of inhibition outgrowth
Function.Nine, the poison that chemicotherapy is caused effect of paying and untoward reaction are played the medical treatment effect: through clinical
Proof,
This medicine is right
Chemicotherapy
Institute causes
One be
Row are anti-
Should, can
Play and subtract
Poison increases
Imitate, carry
High immunity
Ability,
And have
It is white to raise
Cell
Effect.Ten, alleviate the effect of toxicity of anticancer agents: studies show that this medical instrument has the effect that alleviates toxicity of anticancer agents.
Usage and consumption are oral.Every day three times, each 5, (suitably increasing consumption) according to the state of an illness.
Preparation and character preparation: (1) batching: the processing back of will adding medicine to is cleaned with clear water, dries or dries.By prescription medicine being carried out extractum handles
After, oven drying at low temperature, fragmentation is mixed evenly with other medicine then.
(2) pulverize: the pulverizing of will adding medicine to is 120
#Medicated powder.
(3) encapsulated: as to adorn 0
#Capsule.Every 4 gram.The capsule of content uniformity limit must not be more than 2.And must not
Surpass average loading amount ± 10% (dropping preparation method) or ± 15%.Other is by state-promulgated pharmacopoeia rule
The fixed execution.
(4) sterilization treatment: adopt cobalt-60 sterilization, press national Specification and carry out.Character: this product is a capsule.It is faint yellow that powder is.Little salty, bitter.
Taboo and reaction taboo: the careful usefulness of anemia of pregnant woman.Reaction: have no adverse reaction through clinical trial.
Clinical efficacy
Clinical treatment 40 examples; The esophageal carcinoma 20 examples wherein; Carcinoma of gastric cardia 3 examples; Gastric cancer 10 examples: hepatocarcinoma 5 examples; Breast carcinoma 2
Example; Alleviate 20 examples fully; Produce effects 12 examples; Invalid 8 examples.
Main reference document (1) Chen Keyi edits " gastric cancer ", Chinese Medicine science and technology publishing house, and front page in 1999,187-189,
192-195; (2) " traditional Chinese medical science voluminous dictionary " editorial board compiles, " traditional Chinese medical science voluminous dictionary ", Chinese medicine fascicle, trial edition, the people
Publishing house, in 1982, front page; (3) Lang Weijun, Meng Lichun writes, " Chinese medicine medicine for preventing 1,000 sides ", Chinese Medicine science and technology publishing house,, front page in 1999.38-40,56-82; (4) precious one-tenth is compiled " panacea odd-prescription ", the Qinghai People's Press, in 1998, front page.406; (5) Zhang Minqing, the Gong Huiming chief editor, " clinical practice of anti-tumor Chinese medicine " People's Health Publisher, in 1998, front page, 347,414,359,387,261,388,15,89,53,372-373,416-417,398-399,43-44,404-406; (6) Chen Zhiwei, brave, the Xie Weifen volume of woods, " oncology's magazine ",, the first phase, " progress of matrine antitumor mechanism ", 4-6 in 2002; (7) Zhang Yanjun, summer, Zhao Jianbin, " matrine is induced branch people effect to SMMG-7211 cell line " (J), " The Fourth Military Medical University's journal " 1998,19 (3); 340-343; (8) Zhang Baihong, Yue Hongyun, Li Xinmin, " matrine antitumaous effect and inducing apoptosis of tumour cell " (J), " tumor research and clinical " 1999,11 (6): 402-403; (9) Yi Yonglin, Li Wei, Hao Xiuzhi, " Chinese combination of Chinese and Western medicine magazine ", 1993,13 (12): 722-724; (10) Li Wei, Yi Yonglin, Li Zhaohua, " Norman Bethune Medical University's journal ", 1994,20 (4): 384-385; (11) The People's Republic of China Pharmacopoeia Commission of the Ministry of Public Health compiles, the Pharmacopoeia of the People's Republic of China, one one, People's Health Publisher, in 1977 version, in 1982, front page.Appendix 12;
Claims (1)
- Prescription: chaste tree Rabdosia rubescens Herba Hedyotidis Diffusae Herba Sarcandrae Herb Gynostemmae Pentaphylli Lentinus Edodes Herba Chelidonii Pseudobulbus Cremastrae Seu Pleiones unprocessed leech indication and function between Radix Ginseng Radix Astragali Placenta Hominis Colla Corii Asini Cornu Cervi Pantotrichum Radix Panacis Quinquefolii Fructus Mori Semen Cuscutae Radix Et Caulis Acanthopanacis Senticosi pancreas powder Hericium erinaceus (Bull. Ex Fr.) Pers. Coriolous Dersicolor (Fr.) Quel Polyporus Radix Sophorae Flavescentis:Indication: the esophageal carcinoma, gastric cancer, carcinoma of gastric cardia, breast carcinoma, hepatocarcinoma, pulmonary carcinoma, intestinal cancerAnd multiple cancer.Function: benefiting QI and nourishing blood, YIN nourishing and the production of body fluid promoting, warming the kidney to activate YANG, enriching yin and nourishing kidney, spleen invigorating andStomach.Preparation and character:Preparation: (1) batching: the processing back of will adding medicine to is cleaned with clear water, dries or dries.PressAfter prescription carries out the extractum processing with medicine, oven drying at low temperature is brokenBroken, mix evenly with other medicine then.(2) pulverize: the pulverizing of will adding medicine to is 120 #Medicated powder.(3) encapsulated: as to adorn 0 #Capsule.Every 4 gram.The capsule of content uniformity limit is notMust be more than 2.And must not surpass average loading amount ± 10% (dropping preparation method)Or ± 15%.Other is carried out by the state-promulgated pharmacopoeia regulation.(4) sterilization treatment: adopt cobalt-60 sterilization, press national Specification and carry out.Character: this product is a capsule.It is faint yellow that powder is.Little salty, bitter.Ask for protection scope: 1. fill a prescription;2. preparation process;
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02125552 CN1408404A (en) | 2002-07-22 | 2002-07-22 | Cancer curing medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02125552 CN1408404A (en) | 2002-07-22 | 2002-07-22 | Cancer curing medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1408404A true CN1408404A (en) | 2003-04-09 |
Family
ID=4745589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02125552 Pending CN1408404A (en) | 2002-07-22 | 2002-07-22 | Cancer curing medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1408404A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100348117C (en) * | 2005-09-29 | 2007-11-14 | 广东省微生物研究所 | Rainbow-conk bag tea preparing method |
| CN103550517A (en) * | 2013-11-01 | 2014-02-05 | 田静 | Medicine for treating liver cancer |
| CN105194117A (en) * | 2013-03-30 | 2015-12-30 | 刘增智 | Traditional Chinese medicine composition for treating leukemia |
| CN107753545A (en) * | 2017-12-06 | 2018-03-06 | 上海中优精准医疗科技股份有限公司 | A kind of Chinese medicine composition for treating cancer of the esophagus and preparation method thereof |
-
2002
- 2002-07-22 CN CN 02125552 patent/CN1408404A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100348117C (en) * | 2005-09-29 | 2007-11-14 | 广东省微生物研究所 | Rainbow-conk bag tea preparing method |
| CN105194117A (en) * | 2013-03-30 | 2015-12-30 | 刘增智 | Traditional Chinese medicine composition for treating leukemia |
| CN103550517A (en) * | 2013-11-01 | 2014-02-05 | 田静 | Medicine for treating liver cancer |
| CN103550517B (en) * | 2013-11-01 | 2015-07-29 | 苏磊 | A kind of medicine of Hepatoma therapy |
| CN107753545A (en) * | 2017-12-06 | 2018-03-06 | 上海中优精准医疗科技股份有限公司 | A kind of Chinese medicine composition for treating cancer of the esophagus and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1084206C (en) | Cancer treating medicine and its preparation | |
| CN1149094C (en) | Medicinal liquor for treating traumatic injury | |
| CN1408404A (en) | Cancer curing medicine | |
| CN1824155A (en) | Medicine used for kidney supplementing and its preparation method | |
| CN1133725A (en) | Repellent analgesic ointment for cancer or tumor | |
| CN1233354C (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1305513C (en) | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process | |
| CN1424057A (en) | Chinese medicine immunomodulator and its preparation method and use in pharmacy | |
| CN105560145A (en) | Amber mask | |
| CN1537564A (en) | Traditional chinese medicine prepns. for treating broad-spectrum cancers | |
| CN1059333C (en) | Chinese patent medicine for treating various cancers and tumors | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1207012C (en) | Medicine for treating digestive system disease and tumor and preparation method thereof | |
| CN1102335A (en) | Health-care carambola oral liquid | |
| CN1611249A (en) | Antisenescent longevity powder | |
| CN1256117C (en) | A kind of medicine for treating chronic nonspecific ulcerative colitis and its preparation method | |
| CN100337679C (en) | Chinese traditional medicine capable of invigorating yang and strengthening qi and its preparation | |
| CN1864730A (en) | A cancer-treating medicine | |
| CN1222364A (en) | Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof | |
| CN1060659C (en) | Pill medicine for cancer and preparation method | |
| CN1686488A (en) | Medicine for treating malignant tumour and its production method | |
| CN1739678A (en) | Medicine for treating pain caused by wind, cold and wetness evils and its prepn | |
| CN1923247A (en) | Plant medicine for eliminating cancer pain drastically and curing late cancers | |
| CN1058871C (en) | Tianjianwan and producing technology | |
| CN1453020A (en) | Chinese medicine with Yang-strengthening and kidney-benefiting functions and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |